Firm consolidation, thoughtful staffing, disciplined scope control, and performance accountability can save life sciences ...

Emerging biotechs and their investors are exploring partnerships with drug companies at much earlier stages. Experts at ...

On this week's episode, Joel Latham, President and CEO at Incannex Healthcare, talks about developing cannabinoid and psychedelic combination therapies for conditions as diverse as sleep apnea, ...

In the rapidly evolving landscape of pharmaceutical development, AI promises to revolutionize the entire drug discovery and development process, impacting target discovery, clinical trial design, site ...

It was the summer of 2007 when Chris Anzalone, Ph.D., got a call from Arrowhead Research Company. At the time, Anzalone was working as CEO of the Bennet Group, a private equity firm in Washington, D.C ...

The False Claims Act (FCA) and the Anti-Kickback Statute (AKS) are two of the Department of Justice’s (DOJ) primary tools when it comes to fighting fraud. Originally enacted during the Civil War to ...

Recently, there has been heightened focus on dual brand approaches in which the same molecule is approved for multiple indications and packaged, priced, and distributed under different brand names.

We witnessed some amazing accomplishments by the biopharmaceutical industry last year. Just think about all those clinical trials that were executed for the multiple vaccines that we now have access ...

The U.S. Army is a powerhouse of medical research that takes place at multiple facilities worldwide. The mission of Army medical research is to discover, develop, and deploy products that will ...

The number of psychedelic drug developers reaching Phase 2 and Phase 3 clinical trials is growing, in recognition of the level of unmet need in many mental health disorders and other conditions. Those ...

Essential medicines play a vital role in America’s health, and the supply is closely monitored by the FDA and industry groups. These medicines sustain life, provide life support and/or the prevention ...

A real Renaissance man. That’s how some might describe Robert Hariri, M.D., Ph.D. Why? Well, in addition to being a jet aviator, a surgeon, a biomedical scientist, and a successful serial entrepreneur ...